Contract Research
WuXi Biologics Breaks Ground on State-of-the-Art $1.4 Billion CRDMO Facility in Singapore
WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced ...
March 19, 2024 | News
WuXi Biologics attains leadership status in 2023 CDP Climate Change evaluation
CDP runs the global disclosure system for investors, companies, cities, states and regions to manage their environmental impact. In 2023, more than...
March 06, 2024 | News
Medidata and Sanofi Boost Trial Efficiency with Expanded Patient-Centric Collaboration
Medidata, a Dassault Systèmes subsidiary and a leading provider of clinical trial solutions for the life sciences industry, today announced a ...
February 29, 2024 | News
RSSL Launches Innovation Hub for Biotech Support with Labs and Services
RSSL’s Innovation Hub will be a supportive ecosystem for early-stage biotech companies, providing a wide range of tailored services to help t...
February 22, 2024 | News
WuXi Biologics Achieves Milestone with 16,000L Manufacturing Run in Ireland
First manufacturing run successful for MFG7 facility at the Ireland site Largest manufacturing scale to date achieved by combining four 4,000-liter sing...
February 01, 2024 | News
WuXi XDC Partners with Multitude and HySlink for Accelerated ADC Discovery and Development
WuXi XDC will provide a fully integrated, one-stop bioconjugate platform and end-to-end CRDMO services. As WuXi XDC's strategic partner, Multitude Therapeu...
January 31, 2024 | News
Nanoform Achieves Key Milestone in Clinical Trials for Enhanced Enzalutamide
These were from a relative bioavailability study of nanocrystalline-enabled enzalutamide (nanoenzalutamide) tablet formulation, an alternative to the amorp...
January 29, 2024 | News
Catalent Pledges to Slash Greenhouse Gas Emissions by 2030
Catalent, Inc. the leader in enabling the development and supply of better treatments for patients worldwide, announced its targets to reduce greenho...
January 26, 2024 | News
Charles River Streamlines AAV Vector Manufacturing with Rep/Cap Plasmids Launch
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf Rep/Cap plasmid offering, designed to streamline...
January 17, 2024 | News
ClinChoice Strengthens Global Presence with Acquisition of CSI, Ventures into Southeast Asia
Through this strategic acquisition, ClinChoice further broadens its global footprint and full-service capabilities in more than 30 countries throughout&nbs...
January 12, 2024 | News
WuXi XDC Partners with IntoCell to Boost ADC Discovery and Development
Under the agreement, IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate (OHPASTM) Linker and novel...
January 03, 2024 | News
Australian Neuren Phase 2 Trial Reveals Significant Improvements in Phelan-McDermid Syndrome
Highlights: Significant improvement was assessed by both clinicians and caregivers across multiple efficacy measures Improvements were con...
December 19, 2023 | News
Merck Expands Newest Biologics Testing Center in Shanghai
Further develops its biosafety testing laboratories to meet local demand New labs complete 2nd phase of company’s € 29 million...
November 30, 2023 | News
Is Asia ready to be the next global biotech hub?
As outlined in Cytiva’s 2023 Global Biopharma Resilience Index, economies such as Singapore, South Korea, Japan and Australia, are able to pr...
November 28, 2023 | Opinion | By Prem Mandalapu, Commercial General Manager, ASEAN, Cytiva
Most Read
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
